The dog days of summer have ended and the pharma industry heads into the Fall season leaner and focused on year end targets. 'Tis is the season for getting things done.There haven't been any blockbuster breakthroughs yet this year in the oncology or hematology space, but AACR, ASH and the San Antonio Breast Cancer conferences have yet to come.
I wonder who the eventually winners and losers for 2008 are going to be?
No comments:
Post a Comment